Search results for "gea"

showing 10 items of 1040 documents

Grasslands and Shrublands of the Mediterranean Region

2020

The Mediterranean Region extends to the 1.6% of the world’s land surface and more than the half of the Mediterranean-type ecosystems of the world. The remarkable species richness in the Mediterranean Region mainly originates from an exceptional habitat diversity and the presence of several natural barriers facilitating the segregation and differentiation of local taxa and biocoenoses. In this article, we deal with the habitats characterized by grasslands and shrublands that clearly show the adaptations to what could be called “the Mediterranean syndrome”, i.e., the intrazonal Mediterranean grasslands and shrublands (MG&S). The main driving forces of the adaptive radiation and high biodi…

Mediterranean climateEcosystem serviceMesogean floraClimate changeSocio-ecosystemHalo-nitrophilouPhryganaEcosystem servicesShrublandGarrigueMessinian salinity crisiEcosystemWintergreen perennialDry grasslandgeography.geographical_feature_categoryLand useEcologyMaquiGeographyHomeorhetic equilibriumSummergreen perennialHabitatWintergreen ephemeralSettore BIO/03 - Botanica Ambientale E ApplicataSpecies richnessThermo-xerophilouGeographical segregation
researchProduct

Genetic architecture of the marbled goby Pomatoschistus marmoratus (Perciformes, Gobiidae) in the Mediterranean Sea

2011

The marbled goby Pomatoschistus marmoratus, a species inhabiting coastal Mediterranean lagoons, has been studied by measuring its mitochondrial DNA variation. This analysis revealed a Mediterranean west vs east split and, subsequently, an eastern differentiation among the Libyan–Tunisian Gulf, the Adriatic Sea and the Aegean Sea. The high cohesion between the samples collected in the vast area of western Mediterranean contrasts with the genetic mosaic of the more sub-structured eastern Mediterranean. This western homogeneity can not yet be fully explained even if a human-mediated migratory flow, due to a maritime traffic, has been posited. The pattern in the eastern basin revealed a genetic…

Mediterranean climateMarbled gobySettore BIO/05 - ZoologiaDNA MitochondrialPerciformesPomatoschistusEvolution MolecularMediterranean seaGeneticsMediterranean SeaAnimalsMolecular BiologyEcology Evolution Behavior and SystematicsPomatoschistus marmoratus mtDNA Phylogeography Siculo-Tunisian strait Adriatic Sea Aegean Sea Lagoon habitat molecular marker Pomatoschistus marmoratus Mediterranean SeabiologyEcologyGenetic VariationSequence Analysis DNAbiology.organism_classificationPerciformesFisheryPhylogeographyGenetics PopulationHabitatHaplotypesGenetic structureHydrography
researchProduct

Mediterranean circulation perturbations over the last five centuries: Relevance to past Eastern Mediterranean Transient-type events

2016

The Eastern Mediterranean Transient (EMT) occurred in the Aegean Sea from 1988 to 1995 and is the most significant intermediate-to-deep Mediterranean overturning perturbation reported by instrumental records. The EMT was likely caused by accumulation of high salinity waters in the Levantine and enhanced heat loss in the Aegean Sea, coupled with surface water freshening in the Sicily Channel. It is still unknown whether similar transients occurred in the past and, if so, what their forcing processes were. In this study, sediments from the Sicily Channel document surface water freshening (SCFR) at 1910 ± 12, 1812 ± 18, 1725 ± 25 and 1580 ± 30 CE. A regional ocean hindcast links SCFR to enhanc…

Mediterranean climateMultidisciplinary010504 meteorology & atmospheric sciencesAtmospheric circulationEMT010502 geochemistry & geophysics01 natural sciencesArticleBottom waterEastern Mediterranean TransientMediterranean seaOceanographyPaleoceanography13. Climate actionPaleoceanographyNorth Atlantic oscillationAegean SeaAtlantic multidecadal oscillationMediterranean SeacirculationThermohaline circulation14. Life underwaterPaleoceanography; Mediterranean Sea; Eastern Mediterranean transientGeology0105 earth and related environmental sciencesScientific Reports
researchProduct

Neurosurgical Odyssey: Case of Anaplastic Meningiomatosis.

2017

According to the World Health Organization grading, meningiomas are classified as grade I (benign), grade II (atypical), and grade III (anaplastic). Most of them (81%) are benign, 15% are atypical, and 4% are anaplastic. Metastasis is a rare event in meningiomas, occurring in <1% of cases. In most types of tumors, distant metastasis is an incontrovertible indication of malignancy. This is not so clearly the case with meningiomas, mostly in the multiple localization of these tumors, known as meningiomatosis. Here we would like to share our experience with a unique case of an atypical meningioma, which evolved in an anaplastic multiple meningiomatosis, invading the brain and associated wit…

Meningiomatosismedicine.medical_specialtybusiness.industrySettore MED/27 - Neurochirurgiamedicine.diseaseMeningioma03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesismedicineMeningeal NeoplasmsHumansSurgeryNeurology (clinical)RadiologybusinessMeningioma WHO SurgeryMeningioma030217 neurology & neurosurgeryWorld neurosurgery
researchProduct

Chimeric Free Vascularized Metatarsophalangeal Joint With Toe Fillet Flap: A Technique for Reconstruction of the Posttraumatic Metacarpophalangeal Jo…

2018

For painful, dysfunctional, posttraumatic metacarpophalangeal (MCP) joints, the free vascularized toe joint transfer may represent a good solution. Successful reconstruction is potentially limited, however, by 2 features of the traditional vascularized metatarsophalangeal (MTP) transfer: inadequate arc of flexion and insufficient soft tissue coverage. The solution to both of these dilemmas lies in the manner of utilizing the donor site. Because of its innate hyperextensibility, rotating the MTP 180° volar to dorsal provides the greatest arc of flexion in the reconstructed MCP. Excellent soft tissue coverage can be provided by elevating the skin paddle of the transferred second toe as a chim…

Metatarsophalangeal Jointmusculoskeletal diseasesDorsum030230 surgeryFree Tissue Flapsvascularized joint transferPlantar digital artery03 medical and health sciences0302 clinical medicinemedicineHumansMetacarpophalangeal joint; metatarsophalangeal joint transfer; spare parts concept; toe fillet flap; vascularized joint transfer; Humans; Metacarpophalangeal Joint; Metatarsophalangeal Joint; Reconstructive Surgical Procedures; Toes; Free Tissue FlapsOrthopedics and Sports Medicinespare parts conceptFillet (mechanics)Second toebusiness.industrytoe fillet flapSoft tissue030208 emergency & critical care medicineMetacarpophalangeal jointAnatomyPlastic Surgery ProceduresToesSkin paddlebody regionsmetatarsophalangeal joint transfermedicine.anatomical_structureMetacarpophalangeal jointSurgerybusiness
researchProduct

Suprasellar Granular Cell Tumor

1992

A case of a suprasellar granular cell tumor, approximately 1.5 cm in diameter, in a 68-year-old woman is described. Diagnosis was established postoperatively by histopathological examination of the tumor tissue. The preoperative computed tomographic scan revealed a slightly hyperdense suprasellar mass with strong contrast enhancement. There was no evidence of calcification. The T1-weighted image on magnetic resonance imaging scan showed an isointense tumor with non-homogeneous enhancement after intravenous gadolinium diethylene-triamine-pentaacetic acid. In the proton-weighted image, the suprasellar mass presented a non-homogeneously enhanced signal. A non-homogeneous signal reduction was s…

Microsurgeryendocrine system diseasesGadoliniummedicine.medical_treatmentchemistry.chemical_elementPituitary neoplasmCytoplasmic GranulesDiagnosis DifferentialMeningiomaMeningesMeningeal NeoplasmsmedicineHumansPituitary NeoplasmsAgedGranular cell tumormedicine.diagnostic_testbusiness.industryMagnetic resonance imagingAnatomyMicrosurgerymedicine.diseaseMagnetic Resonance ImagingMicroscopy ElectronchemistryPituitary GlandFemaleSurgeryNeurology (clinical)Differential diagnosisMeningiomaNuclear medicinebusinessCalcificationNeurosurgery
researchProduct

Immunohistochemical/histochemical double staining method in the study of the columnar metaplasia of the oesophagus

2014

Intestinal metaplasia in Barrett’s oesophagus (BO) represents an important risk factor for oesophageal adenocarcinoma. Instead, few and controversial data are reported about the progression risk of columnar-lined oesophagus without intestinal metaplasia (CLO), posing an issue about its clinical management. The aim was to evaluate if some immunophenotypic changes were present in CLO independently of the presence of the goblet cells. We studied a series of oesophageal biopsies from patients with endoscopic finding of columnar metaplasia, by performing some immunohistochemical stainings (CK7, p53, AuroraA) combined with histochemistry (Alcian-blue and Alcian/PAS), with the aim of simultaneousl…

Mild Dysplasiap53MalePathologymedicine.medical_specialtyHistologyEsophageal NeoplasmsBiophysicsSettore MED/08 - Anatomia PatologicaBiologyAdenocarcinomadigestive systemBarrett EsophagusEsophagusAntigenMetaplasiamedicineHumansEsophaguslcsh:QH301-705.5Retrospective StudiesMetaplasiaStaining and LabelingBrief ReportBarrett’s oesophagusIntestinal metaplasiaCell Biologymedicine.diseaseImmunohistochemistryEpitheliumdigestive system diseasesBarrett’s oesophagus columnar-lined oesophagus p53 Aurora A kinasemedicine.anatomical_structureBarrett’s oesophagus columnar-lined oesophagus p53 Aurora A kinase.lcsh:Biology (General)columnar-lined oesophagusAdenocarcinomaImmunohistochemistryAurora A kinaseFemaleGoblet Cellsmedicine.symptomEuropean Journal of Histochemistry
researchProduct

Pharmacy and pharmacology of biosimilars

2008

Biosimilar medicines are biological medicinal products that can obtain a marketing authorization in the EU after the original product (biological reference medicine) has run out of patent. As a prerequisite, studies including clinical trials are to be conducted to compare the quality, safety, and efficacy of the biosimilar and reference medicine. Due to the specific characteristics of biopharmaceuticals like complex 3-dimensional (glyco) protein structure, immunogenicity, production in living organisms, which causes heterogeneity, complex manufacturing process and analysis, interchangeability of the biosimilar with its reference drug product is not guaranteed. In addition, INN (internationa…

Models MolecularQuality ControlDrug IndustryTraceabilityEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectPharmacyPharmacyPharmacologyMarketing authorizationInterchangeabilityEndocrinologyPharmacovigilanceHumansMedicineQuality (business)media_commonPharmacologybusiness.industryBiosimilarProduct (business)Pharmaceutical PreparationsTherapeutic EquivalencyImmune SystembusinessAlgorithmsJournal of Endocrinological Investigation
researchProduct

The 1.45 A resolution structure of the cryptogein-cholesterol complex: a close-up view of a sterol carrier protein (SCP) active site.

2002

Cryptogein is a small 10 kDa elicitor produced by the phytoparasitic oomycete Phytophthora cryptogea. The protein also displays a sterol carrier activity. The native protein crystallizes in space group P4(1)22, with unit-cell parameters a = b = 46.51, c = 134.9 A (diffraction limit: 2.1 A). Its complex with cholesterol crystallizes in space group C222(1), with unit-cell parameters a = 30.96, b = 94.8, c = 65.3 A and a resolution enhanced to 1.45 A. The large inner non-specific hydrophobic cavity is able to accommodate a large variety of 3-beta-hydroxy sterols. Cryptogein probably acts as a sterol shuttle helping the pathogen to grow and complete its life cycle.

Models MolecularStereochemistryMolecular Sequence DataBiologyFungal Proteinschemistry.chemical_compoundStructural BiologyAmino Acid SequenceOomyceteBinding SitesMolecular StructureSequence Homology Amino AcidCholesterolPhytophthora cryptogeaResolution (electron density)Algal ProteinsActive siteGeneral Medicinebiology.organism_classificationSterolElicitorSterolsSterol carrier proteinCholesterolBiochemistrychemistrybiology.proteinCarrier ProteinsActa crystallographica. Section D, Biological crystallography
researchProduct

Ramucirumab and its use in gastric cancer treatment

2014

Abstract: The inhibition of the mechanisms of tumor neo-angiogenesis represents a milestone that in the last 10 years has seen the advent of numerous molecules to target action against the vascular endothelial growth factor (VEGF). More recently, new molecules have been developed that inhibit tumor spread by the blockade of specific VEGF receptors (VEGFRs), thereby preventing the binding of a ligand to its receptor and the cascade of proliferative events downstream. Ramucirumab is a fully humanized IgG1 monoclonal antibody that performs its action by blocking the isoform 2 of the VEGF receptor (VEGFR-2). Numerous preclinical and clinical studies have demonstrated its activity in several sol…

Monoclonal antibodyGene isoformmedicine.drug_classAngiogenesisAngiogenesis; Gastroesophageal junction cancer; Metastatic gastric cancer; Monoclonal antibody; Ramucirumab; VEGF receptors; Pharmacology; Pharmacology (medical)Antineoplastic AgentsPharmacologyAntibodies Monoclonal HumanizedGastroesophageal junction cancerMonoclonal antibodyRamucirumabRamucirumabchemistry.chemical_compoundStomach NeoplasmsmedicineHumansPharmacology (medical)ReceptorVEGF receptorsPharmacologyClinical Trials as Topicbusiness.industryPharmacology. TherapyVEGF receptorAntibodies MonoclonalLigand (biochemistry)Vascular Endothelial Growth Factor Receptor-2BlockadeVascular endothelial growth factorAngiogenesichemistryAngiogenesisbusinessMetastatic gastric cancerDrugs of Today
researchProduct